Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PCV-2 vaccine (TVG)
- Development stage
- Preclinical
- Lead developer
- TVG
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
PCV-2 vaccine (TVG) is a herpesvirus-based viral-vector vaccine under development by The Vaccine Group (TVG) for the prevention of Porcine circovirus-2 disease in swine. The vaccine utilizes a proprietary herpesvirus vector platform to deliver and express Porcine circovirus type 2 (PCV-2) antigens, designed to stimulate a robust and protective immune response. Currently in the preclinical stage, this program aims to provide an alternative to traditional PCV-2 vaccines by leveraging the immunogenic properties and delivery efficiency of the herpesvirus vector platform.
- Other names
- Porcine circovirus type 2 vaccinePCV-2 vaccinePCV2 vaccinePCV 2 vaccinePorcine circovirus-2 vaccine
02
Targets
PCV2 Cap (Porcine circovirus type 2 capsid protein)
Beyond the preview
Go deeper on PCV-2 vaccine (TVG).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PCV-2 vaccine (TVG).